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There is a growing imperative to improve the coordination and collaboration of tuberculosis (TB) and HIV
healthcare services in response to escalating rates of TB/HIV coinfection. Patient-specific challenges associated
with the delivery of TB/HIV care have been minimally explored in this regard. As part of a larger study conducted
in South Africa, this article highlights coinfected patients’ experiences with TB and HIV healthcare in light of
their broader social environments. Qualitative, in-depth interviews were conducted with 40 adult, coinfected
patients (24 women and 16 men) and eight key-informant healthcare workers at three urban/peri-urban,
ambulatory, public health clinics in the high-burden province of KwaZulu-Natal. Transcribed interviews were
analyzed under a modified grounded theory approach to capture subjective meanings of healthcare experience
subsequent to patients’ codiagnosis with TB and HIV. Emerging analytic themes highlighted critical sociomedical
constraints to TB/HIV care in relation to patients’ income and employment, eligibility for social assistance and
antiretroviral treatment, fears around illness disclosure, social and material support, and treatment adherence.
Patients’ healthcare experiences were bound by their poor access to essential resources, multiple life
responsibilities, disparate gender roles, limits within the healthcare system, and the stigmatizing social symbolism
of their illness. Overlapping social inequalities perpetuated coinfected patients’ experiences with stigma and
collectively mediated their health decisions around disclosure, adherence, and retention in medical care. The
study urges a contextualized understanding of the social challenges associated with TB/HIV healthcare and helps
inform more patient-sensitive and socially responsive interventions against the co-epidemic.
Keywords: South Africa; patient perspectives; TB/HIV coinfection; integration; qualitative methods
Introduction
In South Africa, approximately 73% of new TB cases
are HIV-coinfected and 84% of TB deaths are
attributable to HIV/AIDS (Padarath & Fonn, 2010).
Women and those living in poverty are disproportio-
nately affected (Abdool Karim, Churchyard, Abdool
Karim, & Lawn, 2009). Integration of TB and HIV
services may decrease the clinical and social impact of
coinfection. However, fewer than 50% of TB patients
know their HIV status and only 42% of those eligible
receive antiretroviral treatment (ART) (Padarath &
Fonn, 2010; WHO, 2010).
Relatively little is understood about patient-
specific challenges with TB/HIV healthcare. We
highlight coinfected patients’ perspectives toward
understanding their experiences with dual care. Our
analysis stems from a broader examination of the
social contexts of TB/HIV coinfection.
Methods
This qualitative study was set at three urban/periur-
ban, ambulatory, public sector clinics providing TB
and/or HIV services in KwaZulu-Natal province,
with a TB incidence of 1066/100,000 population and
26% adult HIV prevalence (Padarath & Fonn, 2010).
Over 6 months in 2009, 40 coinfected adults partici-
pated in a private, audio-recorded, in-depth interview
(N141313). Heterogeneous sampling (Patton,
2002), including patients of varying treatment
stage, marital, and employment status, maximized
the diversity of experiences analyzed. Patients aged
1850 years and a higher proportion of women were
purposively recruited, following their higher HIV
prevalence (Padarath & Fonn, 2010). Open-ended
interviews were tailored to patients’ individual cir-
cumstances, specifically their healthcare experiences
subsequent to co-diagnosis. Eight key-informant
healthcare workers (HCWs) were also interviewed
to contextualize patients’ responses (N323).
All participants provided written, informed consent.
Patients were compensated ZAR50.
Interviews averaged 41 and 65 minutes with
patients and HCWs, respectively. Transcripts were
anonymized and analyzed using modified grounded
theory (Denzin & Lincoln, 2000; Seale, Gobo,
Gubrium, & Silverman, 2004). Substantive and
selective coding identified emergent themes and
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latent patterns toward the development of theore-
tical concepts. The study received ethics approval
from University of KwaZulu-Natal, South Africa
and University of Toronto, Canada.
Heterogeneous, purposive sampling and qualita-
tive analysis precluded drawing conclusive associa-
tions between participants’ characteristics and
healthcare experiences. Self-reported data were not
objectively validated. Findings may not be general-
izable, particularly to rural patients and those not yet
diagnosed or accessing care. However, they offer
novel insight to patient-specific challenges that may
affect TB/HIV healthcare outputs in similar high-
burden settings.
Findings
Patients’ self-reported characteristics are shown in
Table 1. All were accessing healthcare services,
including 38 on TB chemotherapy (since one day to
10 months) and 31 on ART (since one week to five
years). Interview excerpts highlighting the study
findings are shared in Table 2.
Income and employer support
Coinfected patients, particularly women abandoned by
their partners, were imminently concerned about
sustained access to resources. Unemployment forced
many to live with extended family. Patients described
having inadequate food to tolerate drug regimens and
insufficient funds to commute to clinics. Those em-
ployed had to discontinue work temporarily to access
care. Formally employed patients received some com-
pensation for TB, but most others engaged in in-
formal/part-time work received no support. Several
women who were let go after disclosing TB believed it
was due to an implicit (stigmatizing) association with
HIV. Patients did not disclose HIV at work.
Most patients were primary caregivers to their
families. Men were considered financial providers and
generally supported by their partner, mother or
neighbor when looking after children. Women were
considered direct caregivers and financial providers.
They tended to siblings, older relatives, children
including those of deceased relatives, and more
intently described setting aside their illness to earn
for their dependents.
Table 1. Sociodemographic and clinical characteristics of patient participants.
Patient characteristics Total (%) Women (%) Men (%)
Total 40 24 (60) 16 (40)
Agea
Range (years) 2147 2147 2246
Average (years) 34 33 34
Marital status
Married or in a sexual relationship 25 (63) 12 (50) 13 (81)
Single 15 (37) 12 (50) 3 (19)
With]1 child 30 (75) 16 (67) 14 (88)
Employment statusb
Employedc 19 (48) 8 (33) 11 (69)
Unemployed 20 (50) 16 (67) 4 (25)
Unemployed due to TB or HIV (as% total unemployed) 12 (60) 10 (63) 2 (50)
Type of TB
Pulmonary 28 (70) 19 (79) 9 (56)
Extrapulmonary 12 (30) 5 (21) 7 (44)
Diagnostic historyd
Diagnosed with HIV during TB symptom investigation 22 (55) 12 (50) 10 (63)
Diagnosed with HIV after TB notificatione 3 (8) 1 (4) 2 (12)
Diagnosed with TB after HIV diagnosisf 14 (35) 11 (46) 3 (19)
aThe exact age was unknown for three patients.
bThe employment status was unknown for one patient.
cTen patients said they were engaged in informal or temporary work (street/retail venders, domestic workers, cleaners, taxi drivers, garden,
paint or tile contractors, and assisting with partner/family business). Seven patients said they were formally employed (by hospitals, business
offices, and police or security services). Two patients said they operated their own small businesses.
dThe diagnostic history was not clear for one patient.
eThree patients said they specifically delayed HIV testing from 1 month to 1 year after TB notification.
fFourteen patients said they developed TB between 9 months and 9 years after HIV diagnosis.
































Table 2. Interview excerpts highlighting study findings.
Income and employer support
No, [my mother and sister] is not working, even me and now am not working. Sometimes I’ve got no food. Sometimes I want to
drink the tablet, I’ve got no food . . . there’s my problem. (F, 37y)
People cannot accept person with these diseases because they scared that she might infect others . . . Such that where I was
working, they knew that I have this thing, such that they asked me to go. (F, 31y)
I couldn’t tell [my employers]. They were going to make fun of me . . . some people are so arrogant, they don’t understand . . . even
with TB they don’t understand, ‘cause they think if you have TB, you have AIDS. (F, 23y)
I stayed, I continued at work. Then by [month], I realize that it’s too difficult for me. It’s not me who’s working, it’s my heart who
is working because I’m supposed to support [my children]. (F, 30y)
Social assistance
That story about CD4 count for getting a grant is rubbish . . . because many people can’t use medication without eating . . . You
must be able to eat, so that that thing can work. If you only eat medication, that thing will work on you but your body will feel
weak . . . My grant close, I don’t want to go back, ‘cause I know I’m not going to qualify. (M, 34y)
The time goes on, I decided to leave the job . . .When I was pressing this for TB, for them to try for with the pension so that my
children can get food . . . this pension, they didn’t give me, they said my CD4 count, as it was saying [200], I won’t be able to get
the one for TB. (F, 30y)
Unfortunately, if you go to certain department of social offices, you get a grant more easily than others. If you’re going to [name
of town] and they send you to their district surgeon, you got to be I think dead before you’ll get a disability grant. Guys who’ve
been really, desperately ill . . . I tell them, get a wheelchair or carry them into the room, I said, because they might believe you then.
(HCW)
There were quite a few patients on TB treatment . . . they were cured and could have been discharged, but if you had ask them
of their symptoms, they’re quite clear . . . they’ll say ‘No’, they’re still coughing, they still have night sweats . . . Its because they
don’t want the grant to stop . . . And the same thing for the HIV . . . they have the grant, which is meant to be temporary for a year,
and then normally when their CD4 count is above 200, it’s stopped. It’s not renewed. And you see a lot of patients who know that
already now, and they start to stop taking their medication because they want their CD4 count to drop because they don’t want the
grant to stop. (HCW)
Disclosure versus support
Now because I so sick, my cousins, they are looking after my son, and they bring him home on weekends. And I just feel I’m not
ready to tell them. Because they will just like, they make a big deal out of the little petty things he does. He’s only 6 years old and
if I must tell them this thing, it’ll be like oh . . . They know I’ve got TB but they don’t know about the HIV. (F, 36y)
I didn’t tell [my employers]. I just said that I am suffering from TB, what else was I supposed to say . . . they took me so good
but I didn’t tell them about the other thing. I don’t know how would they behave if they can ever hear that I’m having that?
(F, 47y)
Even now we are still together. The only thing is I haven’t disclosed to him that I’m HIV . . .We haven’t been together since I was HIV
diagnosed . . . He comes and we chat, its nice . . . I told him because he wanted to know what really makes me sick. I told him I have
TB, but I’m planning to  how to start him because I don’t know how I got it . . . I still want the way of telling him. (F, 31y)
Patients sometimes find it convenient to have TB because it means that they can tell their employers that they’re coming to
collect TB treatment. Meantime they’re also coming [to the HIV clinic] . . . When they finish their TB treatment, some of
the guys have been, ‘What am I going to do now, because my boss knows I’ve finished TB treatment and I’m still going to
come [to the HIV clinic]? What can I tell him?’ and that’s been quite an issue... they’ve lost their excuse. Some times we’ve
actually written letters just to say that this patient requires essential treatment . . . I just say, enough said, essential treatment.
(HCW)
Delays with ART
You bring the person and you can see that this person is very sick. They will just check the person and find out that she is positive. Then
they will refer the person to the nearest clinic . . . it can take even 18 months, still attending up until she dies . . . Out of ten people only
two were they saying the CD4 is going down, all others are right . . . but you can see that this person is finished. (F, 35y)
Sometimes when the doctor said, it was 200[X], he said I have to come back after 6 months. But I just ignored. My CD4 count
was saying [300], but I just forget about that up until its now, when I’m coming back. (F, 30y)
They did a letter because of course my CD was low. I must go that [HIV clinic], it was [B200] . . . They told me that they won’t
be able to start me early because I have just started the TB treatment. They asked me to wait . . . they told me to wait 3 months or


































Eligibility for government-issued disability grants was
understood to be based on patients’ CD4 counts.
Tuberculosis did not guarantee approval. That ART
and TB chemotherapy raised counts above the
eligibility threshold left many patients feeling power-
less and resentful of the social assistance program.
HCWs echoed how grant criteria neglected patients’
social circumstances, with potential negative clinical
consequences. They had treated patients who de-
faulted from care to maintain low CD4 counts.
Disclosure versus support
Patients balanced illness disclosure against the loss of
social support. Women, in greater need of financial
and material aid, routinely disclosed TB in exchange
for childcare support but feared it would end if their
HIV status became known. Those who had experi-
enced breakups during earlier HIV disclosures
avoided disclosing to new boyfriends. They used TB
as justification for requesting money and avoiding
sex. HCWs recounted their patients used TB as an
‘‘excuse’’ to stave off the greater perceived stigma
associated with HIV.
Patients who accessed employer-support confined
discussions at work to TB. Others feared prevailing
public assumptions tying TB to HIV and disclosed
neither. They encountered greater difficulty keeping
clinic appointments; some altogether stopped work
without providing a reason. HCWs had to carefully
word letters to employers, on patients’ explicit
request, highlighting TB but without any reference
to HIV.
Table 2 (Continued)
[My CD4 count] said [B200] . . . They said I am supposed to use tablets, the ARVs . . . I am going to use them but I just want to
finished these ones for TB first . . . I just said as I was sick, going to do CD4 count, didn’t have power. (M, 25y)
The government is overloaded, so most of the patients are on the waiting list for too long, and they die. Most of them die whilst on
the waiting list. But what I picked up is that the community is still confused about when the patient must take ARVs . . . You’ll find
that even the healthcare workers outside are preaching this gospel . . . stopping the patient from taking TB treatment and telling
them, ‘TB treatment is going to kill you if you take it whilst, when you on ARVs. So, park the ARVs, take the TB treatment’.
Patients get confused, they get sick . . . and they die. (HCW)
Fears to adhere
I hide ARVs. I hide them because I just lock my suitcase . . . I will put them in my breast knowing that if it’s for me to drink them,
[my cousin] won’t see me . . . [TB] she knows because she even ask if I’ve drank them if she is available. Maybe I haven’t them
yet, then she will say, ‘Hey, go and drink them’. (F, 31y)
I never took it yesterday . . . House is always full. It’s not easy to take tablets, 5 tablets and use it in front of people. They think,
this man have got AIDS or you know like that. No, the shame is there . . . That’s only thing why I skip my TB sometimes, but I do
it in the morning. They say there is no cover up. If you miss, you miss . . . ARVs sometimes it goes the same too, it goes the same.
(M, 34y)
I wanted this thing, this thing to be finished [points to enlarged neck, from glandular TB] . . . because everybody . . . they are
looking at you, so I was so embarrassed. People are looking at you, so that’s why what make me not forget to take this tablet. (F,
33y)
In 200[X], I make a CD4. I found my CD4 is also [B100]. I was supposed to start ARVs. So I get a counselling, all that stuff . . .
When I start to use it, my body was so thin . . . so when I using it, I become big. So I say, too big now so I decide to leave it. I leave
it maybe it was the whole year, 200[X] up to 200[X]. So after that I found that now I am sick . . . I asked myself what is going on
inside now? So now I remember no, I leave that treatment . . . I go to make a check up for the TB so I found out that I have TB . . .
told the doc that I got a, I leave to use my ARVs, my treatment. So he make a note for me so that I must got back to my clinic . . . I
was lying when they asked me. I said, I was going with a job so I didn’t remember to make the, all different stuff so they believe
me. (M, 37y)
When I first check, they said I must go to the clinic... I just said, you know what? I’m feeling well so what, why am I coming here?
Because people are going to see me. I was still young. Why am I coming? . . . People are going to laugh at me. They going to spread
this . . . it’s not even a rumor, it’s the truth, and I was scared of that. So I just said no, its quits, let me go back to my life. Why not
do something else than come here every month . . . imagine the rumor just going around, you know, people saying, you know ‘I saw
her at [clinic]’, because you know the [clinic], it’s so close to the road, like, the cars just pass. They just pass by. They can see.
Even if you can’t see them, they saw you. You can’t say, ‘No, you never saw me’, so that’s why I quit going there. (F, 21y)
F, female patient; M, male patient; HCW, key-informant healthcare worker.
Note: Patient participants’ self-reported CD4 counts, health-related timelines and diagnostic details, shared during study interviews, have
been replaced with approximations to maintain confidentiality and anonymity.

































During the study, the national ART program man-
dated eligible patients’ CD4 counts fall below 200
cells/mm3, regardless of TB coinfection (NTCP,
2008). This worried patients who had witnessed
others succumb to illness waiting for their counts to
drop. HCWs voiced that TB patients should initiate
ART irrespective of set indicators. They complained
that program saturation and the poor dissemination
of TB/HIV protocols further aggravated co-treatment
delays.
Several patients diagnosed with HIV years prior
were initially denied ART due to their higher CD4
counts. ART ineligibility and apparent physical well-
being disinclined them from accessing care until they
became acutely ill with TB. Some other patients
deferred or discontinued ART despite clinical elig-
ibility. One patient, stressed after his partner left him,
lost the ‘‘amandla’’ or power to deal with multiple
issues at once. He refused to initiate ART until
completing TB treatment. Another patient stopped
ART once he started to gain weight. It was only the
physical deterioration caused by TB that prompted
him to reconnect with HIV care.
Fears to adhere
Patients used telephone alarms or popular television
broadcasts as cues for adherence. Sometimes, a
partner or relative reminded them despite being
unaware of the patients’ HIV illness; often, patients
had disclosed they were just receiving treatment for
TB. Others feared any illness could be perceived as
HIV and routinely hid their medications, delayed, or
skipped a dose to avoid being exposed and stigma-
tized.
The fear of being discriminated against pushed
several patients to remain secretive about having HIV
and neglect accessing care, particularly when they
were also asymptomatic and/or ineligible for ART.
Conversely, the fear of being labeled due to overt
symptoms, such as enlarged lymph glands, promoted
adherence among some patients with extrapulmonary
TB. They were keen to shed symptoms that they
perceived were more indicative of HIV.
Discussion
To our knowledge, this is one of the first studies
examining coinfected patients’ experiences navigating
TB and HIV healthcare. Findings highlight how
competing constraints, many beyond patients’ direct
control, intercept with broader issues of socioeco-
nomic and structural inequality to collectively med-
iate health decision-making.
Socioeconomic constraints
While the financial burden of coinfection, due to
indirect medical costs and job loss, is suggested by
prior research (Chileshe & Bond, 2010; Sadoh &
Oviawe, 2007), patients’ limited access to social
assistance is poorly documented. A recent survey
highlights government subsidies are routinely denied
to patients with a CD4 count above 200 cells/mm3,
despite this being an unreliable indicator of their
functional ability (Phaswana-Mafuya, Peltzer, &
Petros, 2009). Our study substantiates how clinical
markers may neglect the dual morbidity and social
constraint that coinfected patients are unable to
escape from. Studies also show coinfected patients
disclose TB to escape HIV-associated stigma (Coreil
et al., 2010; Daftary, Padayatchi, & Padilla, 2007;
Ngamvithayapong, Winkvist, & Diwan, 2000). In our
study, selective disclosures were additionally moti-
vated by patients’ need to access resources, which
may have been denied had they disclosed HIV.
Unemployment, partner abandonment and the
burden of caregiving appeared to be higher among
women participants. In greater need of financial and
child support, they balanced illness disclosures more
cautiously. Research shows their subordinate social
position and family obligations may leave women
with little agency to prioritize their health (Johansson,
Long, Diwan, & Winkvist, 2000; Krishnan et al., 2008;
Tarimo, Kohi, Outwater, & Blystad, 2009), and dis-
proportionately impede their retention in care (Geng
et al., 2010).
Health system constraints
Health system deficiencies and stringent policies
inhibited study patients’ access to co-treatment. A
study from Zambia reveals system-level and socio-
economic barriers collectively disable patients from
accessing ART (Chileshe & Bond, 2010). Our study
further highlights how these structural barriers,
particularly ART ineligibility, may compound pa-
tients’ predispositions to interrupt care. Recent re-
commendations to initiate ART in all TB patients,
regardless of CD4 counts, should expedite co-treat-
ment and facilitate healthcare retention (WHO, 2009).
Our study points to accelerated attrition among
patients who felt physically well. Attrition is found to
be greater among patients with high CD4 counts who
are ineligible for ART (Geng et al., 2010). We found
the stigma associated with HIV additionally influ-

































care. This may explain the high loss to follow-up
recorded by national HIV programs (Padarath &
Fonn, 2010).
Stigma
Stigma underscored study patients’ health decisions.
The relatively greater stigma of HIV encouraged
patients to disclose TB over HIV and prompted
non-adherence, as has been shown in prior work
(Daftary, Padayatchi, & Padilla, 2007; Deribew
et al., 2010; Gebremariam, Bjune, & Frich, 2010;
Naidoo, Dick, & Cooper, 2009). Our study highlights
that the effect of stigma may persist despite ART
access and unequally with regards to TB versus HIV
care. Patients who interrupted HIV treatment did not
report similar actions vis-à-vis TB. The role of stigma
in patients’ decisions may also be non-linear. The
stigma of being identified at clinics and labeled with
HIV discouraged adherence among some patients.
However, the stigma of HIV-associated symptoms
encouraged adherence among others.
Social scientists theorize that disease-related stig-
ma reproduces the effects of existing social inequal-
ities. It is the foundation of these inequalities, and
accompanying loss of power and social status, that
renders stigma to be disproportionately experienced
by individuals who are also the most marginalized
(Link & Phelan, 2006; Parker & Aggleton, 2003). Our
study exemplifies how socioeconomic and structural
disparities, including gender-based inequality and
ART ineligibility, may perpetuate patients’ suscept-
ibility to stigma and render their healthcare decisions
to be socially informed.
In foregrounding the voices of coinfected patients,
this study highlights important social constraints to
TB/HIV healthcare (we share the study implications
in Table 3). Inclusion of this contextualized perspec-
tive is urged toward developing more patient-sensitive
and socially responsive interventions.
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